Silodosin Capsule Uses in Pakistan

Silodosin (brand: Urimax, Silodyx) is a highly selective alpha-1A blocker used in Pakistan for urinary difficulty caused by BPH (prostate enlargement). This guide covers all approved uses and essential precautions.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-06-17

Uses

Quick Answer

Silodosin (Urimax / Silodyx) is used in Pakistan for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) — including intermittent urination, weak stream, frequent urination, and nocturia. It relaxes the smooth muscle of the prostate and bladder neck to improve urine flow. Take only on a doctor's prescription.

Primary Uses at a Glance

BPH — Benign Prostatic Hyperplasia (Prostate Gland Enlargement)

Silodosin's primary approved use is for LUTS (lower urinary tract symptoms) caused by BPH. When the prostate gland enlarges, it compresses the urethra. Silodosin blocks the alpha-1A receptors in the prostate and bladder neck, relaxing smooth muscle — reducing resistance and improving flow. Symptoms include intermittent urination (hesitancy), weak stream, and incomplete bladder emptying.

On a doctor's prescription. Standard adult dose: 8mg once daily with food.

LUTS — Lower Urinary Tract Symptoms (Nocturia, Frequency, Urgency)

BPH also causes nocturia, daytime frequency, and urgency. Silodosin relieves all these symptoms through prostate relaxation. Nocturia improvement is particularly important for quality of life.

On a doctor's prescription. 8mg once daily with the evening meal.

Other Uses

Urgency-frequency syndrome due to BPH
Incomplete bladder emptying

Silodosin Capsule Uses (Fayde / Kis kaam aata hai)

Silodosin (Urimax, Silodyx) is a highly selective alpha-1A adrenergic receptor antagonist. It is prescribed in Pakistan for LUTS caused by BPH.

Primary Uses (Mukhya Istemal)

BPH — LUTS: intermittent urination, weak stream, incomplete emptying, frequency, urgency, nocturia
Benign Prostatic Hyperplasia — reduction of urethral resistance through prostate muscle relaxation

Who Should Take It (Kin logon ke liye)

Adult male patients with a confirmed diagnosis of BPH
LUTS symptoms — hesitancy, weak stream, nocturia, frequency — for whom the doctor has prescribed an alpha-blocker

When NOT to Use Silodosin (Kab nahi leni)

With strong CYP3A4 inhibitors (ketoconazole, ritonavir) — CONTRAINDICATED
Severe hypotension
Severe renal impairment (eGFR < 30)
When planning for fertility (ejaculatory dysfunction — consider alternative)
Female patients or children

Summary

Silodosin (Urimax, Silodyx) is an effective alpha-1A blocker for LUTS caused by BPH. The risk of ejaculatory dysfunction (~28%) is very high — the patient must be informed before starting. Take only on a doctor's prescription.

The information in this guide is for educational purposes only.

Frequently Asked Questions

Silodosin kis kaam aata hai?

Silodosin is used for urinary difficulty caused by BPH (prostate enlargement) — intermittent urination, weak stream, frequent urination, and nocturia. Relaxing the muscles of the prostate and bladder neck improves urine flow.

Silodosin kitne waqt mein asar dikhaata hai?

Most patients notice improvement in urine flow within 1-2 weeks of starting silodosin. Full effect takes 4-6 weeks. Regular use is essential.

Kya silodosin prostate size kam karta hai?

No — silodosin only relaxes muscle (alpha-1 blocker). To reduce prostate size, 5-alpha reductase inhibitors (finasteride, dutasteride) are used. Both are often combined for an enlarged prostate.

Silodosin kab tak leni hai?

BPH is generally a lifelong condition — symptoms may return on discontinuation. The doctor will decide on the long-term plan.

Kya silodosin female patients mein use hoti hai?

No — silodosin is approved only for adult male patients.

Brand alternatives, same-class options, and other medicines used for the same conditions as Silodosin Capsule.

Used for the same conditions

Other medicines commonly used for high blood pressure (hypertension) and overlapping conditions.

High Blood Pressure (Hypertension) hub →

Sources

DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.